Neurological Presentations in Patients with COVID-19 in Cytokine Storm
Open Access
- 29 October 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 50 (1) , 89-95
Abstract
Background: Coronavirus disease 2019 (COVID-19) infection causes a wide variety of neurological disorders by affecting both central and peripheral nervous systems. The cytokine storm (CS) has been blamed for the development of severe neurological disorders in COVID-19. However, the relationship between COVID-19 CS and neurological manifestations has not been adequately studied. Thus, we aimed to investigate the neurological presentations in patients with COVID-19 CS.Methods: The study population consisted of hospitalized moderate-to-severe COVID-19 patients. It was divided into two groups CS (36 patients, 29.3%) and non-CS (87 patients, 70.7%) based on significant clinical symptoms, elevated inflammatory marker levels, radiological findings, and interleukin-6 levels (IL-6).Results: The three most common neurological symptoms in the CS group were altered level of consciousness, headache, and unsteadiness. Altered level of consciousness was higher in the CS group (69.4%) than the non-CS group (25.3%) (p:0.001). The frequency of headache was comparable in both groups (p:0.186). The number of patients requiring intensive care unit and intubation was higher in the CS group (p:0.005 and p:0.001). The mortality rate in the CS group (38.9%) was higher than the non-CS group (8.0%) (p:0.001). IL-6, CRP, ferritin, neutrophil-lymphocyte ratio, procalcitonin, and D-dimer levels were higher in the CS group (for all p:0.001) while lymphocyte count was lower (p:0.003).Conclusion: The most common neurological presentation in patients with CS was altered level of consciousness. The presence of CS was an independent risk factor for high mortality.Keywords
This publication has 32 references indexed in Scilit:
- Neurological manifestations and COVID-19: Experiences from a tertiary care center at the FrontlineJournal of the Neurological Sciences, 2020
- Neurological Manifestations of COVID-19 (SARS-CoV-2): A ReviewFrontiers in Neurology, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine, 2020
- COVID‐19 is a Real Headache!Headache: The Journal of Head and Face Pain, 2020
- Neurological Manifestations of COVID‐19: A systematic review and current updateActa Neurologica Scandinavica, 2020
- On the Alert for Cytokine Storm: Immunopathology in COVID‐19Arthritis & Rheumatology, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- The many faces of the anti-COVID immune responseJournal of Experimental Medicine, 2020
- Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19Journal of Medical Virology, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020